Data / Form D filings / Athos Therapeutics, Inc.
Athos Therapeutics, Inc.: Form D filings
Athos Therapeutics, Inc., a pharmaceuticals company in Torrance, CA, filed 4 Form D notices with the SEC between 2021 and 2026. The latest, on May 15, 2026, reports $10.3 million sold of a $20 million offering to 40 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1123 W. CARSON ST., Torrance, CA, 90502
- Phone
- (857) 222-0410
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1885079
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 15, 2026 | New notice | $20,000,000 | $10,282,887 | $9,717,113 | 40 | Apr 17, 2026 | sec.gov |
| Feb 6, 2024 | New notice | $34,999,995 | $7,556,334 | $27,443,661 | 30 | Jan 22, 2024 | sec.gov |
| Nov 17, 2021 | Amendment | $20,416,499 | $20,416,499 | 103 | Sep 15, 2021 | sec.gov | |
| Sep 28, 2021 | New notice | $19,660,000 | $13,179,839 | $6,480,161 | 58 | Sep 15, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Dimitrios Iliopoulos | Executive Officer, Director | |
| Allan J. Pantuck | Executive Officer, Director | |
| Carl McKinzie | Director | |
| Joel Cohen | Director | |
| Anthony Zingale | Director | |
| Laurence Stein | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of May 11, 2026 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Athos Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.